TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
30,783
|
75,822
|
43,558 |
| Financial expenses |
2,256
|
2,349
|
13,372 |
| Earnings before taxes |
926
|
2,702
|
1,482 |
| EBITDA |
1,274
|
1,249
|
-1,291 |
| Total assets |
54,003
|
35,706
|
27,639 |
| Current assets |
53,821
|
35,518
|
26,360 |
| Current liabilities |
47,964
|
27,147
|
21,369 |
| Equity capital |
5,742
|
8,252
|
6,102 |
| - share capital |
174
|
180
|
180 |
| Employees (average) |
16
|
14
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.6%
|
23.1%
|
22.1% |
| Turnover per employee |
1,924
|
5,416
|
3,111 |
| Profit as a percentage of turnover |
3.0%
|
3.6%
|
3.4% |
| Return on assets (ROA) |
5.9%
|
14.1%
|
53.7% |
| Current ratio |
112.2%
|
130.8%
|
123.4% |
| Return on equity (ROE) |
16.1%
|
32.7%
|
24.3% |
| Change turnover |
-42,461
|
32,137
|
24,249 |
| Change turnover % |
-58%
|
74%
|
126% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
14%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.